<DOC>
	<DOCNO>NCT02946892</DOCNO>
	<brief_summary>This study evaluate effect carvedilol patient undergone Fontan heart operation . All participant receive carvedilol placebo 12 week . Exercise test perform end 12 week period .</brief_summary>
	<brief_title>Effect Carvedilol Exercise Performance Fontan Patients</brief_title>
	<detailed_description>Carvedilol well study heart failure medication adult heart failure show improve outcome . However , study patient Fontan heart operation . Study participant receive either placebo carvedilol 12 week , end 12 week participant perform exercise test . Then study participant receive treatment placebo carvedilol 12 week ( opposite participant go first 12 week ) perform exercise test .</detailed_description>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>1 . Informed consent parent ( ) legal guardian ; inform consent assent subject applicable . 2 . Male female child age 10 35 year congenital heart disease palliate Fontan circulation . 3 . Ability perform maximal exercise test define respiratory exchange ratio ( RER ) great 1.0 time maximal exercise 1 . The use beta blocker within 2 month randomization 2 . Patients actively list transplantation time entry study anticipate undergo heart transplantation , interventional catheterization , corrective cardiac surgery 7 month follow entry study 3 . Sustained symptomatic ventricular dysrhythmias uncontrolled drug therapy use implantable defibrillator , and/or significant cardiac conduction defect , e.g. , 2nd degree 3rd degree AV block , sick sinus syndrome , unless function pacemaker place 4 . Uncorrected obstructive severe regurgitant valve disease , nondilated cardiomyopathy , significant systemic ventricular outflow obstruction 5 . Known renovascular hypertension evidence pulmonary hypertension ( pulmonary vascular resistance &gt; 6 Wood unit ) unresponsive vasodilator agent oxygen , nitroprusside , nitric oxide 6 . History current clinical evidence moderatetosevere fix obstructive pulmonary disease severe reactive airway disease ( e.g. , asthma ) require hospitalization within past 2 year patient currently use longterm inhaled bronchodilator 7 . Renal , hepatic , gastrointestinal , biliary disorder could impair absorption , metabolism excretion orally administer medication 8 . Concurrent terminal illness severe disease ( e.g. , active neoplasm ) significant laboratory value ( ) , opinion investigator , could preclude participation survival 9 . Endocrine disorder primary aldosteronism , pheochromocytoma , hyper hypothyroidism , insulindependent diabetes mellitus 10 . Unwillingness inability cooperate , parent guardian give consent , child give assent , condition sufficient severity impair cooperation study 11 . Pregnancy possible pregnancy time randomization , female child bear potential lactating , sexually active take adequate contraceptive precaution ( e.g. , intrauterine device oral contraceptive 3 month prior entry study ) 12 . Use investigational drug within 30 day randomization , within 5 halflives investigational drug ( long period apply ) 13 . History drug sensitivity allergic reaction alphablockers ÃŸblockers 14 . Use following medication within two week randomization : MAO inhibitor , Calcium channel blocker , alpha blocker , beta blocker , disopyramide , flecainide , encainide , moricizine , propafenone , sotalol , beta adrenergic agonists 15 . Hospital admission protein lose enteropathy plastic bronchitis within 3 month randomization 16 . Active and/or chronic protein lose enteropathy plastic bronchitis ( inhaled medication control plastic bronchitis ) . 17 . Hypoalbuminemia define serum albumin &lt; 2.0g/dL 18 . Renal dysfunction define serum creatinine &gt; 2.0mg/dL 19 . Hepatic dysfunction define serum AST and/or ALT &gt; 3 time upper limit normal ( approximately 120 IU/L however , vary depend age ) , 20 . Significant anemia polycythemia define hemoglobin &gt; 18gm/dL hemoglobin &lt; 7gm/dL 21 . Severely elevated serum BNP define BNP &gt; 300pg/ml</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>